Insight Molecular Diagnostics Inc.
IMDX
$4.01
$0.184.70%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -22.96M | -10.85M | -9.74M | -6.67M | -33.51M |
| Total Depreciation and Amortization | 563.00K | 584.00K | 559.00K | 491.00K | 563.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14.26M | 4.11M | 3.38M | 1.37M | 28.72M |
| Change in Net Operating Assets | 2.59M | 1.66M | -478.00K | -1.04M | -1.12M |
| Cash from Operations | -5.55M | -4.50M | -6.28M | -5.86M | -5.35M |
| Capital Expenditure | -1.48M | -1.05M | -349.00K | -307.00K | -214.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 4.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1.48M | -1.05M | -349.00K | -307.00K | -210.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -358.00K | -120.00K | -114.00K | -98.00K | -82.00K |
| Issuance of Common Stock | 0.00 | 0.00 | 0.00 | 29.14M | 11.99M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | 0.00 |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -146.00K | 0.00 | 0.00 | -487.00K | -1.07M |
| Cash from Financing | -252.00K | -120.00K | -114.00K | 28.56M | 10.84M |
| Foreign Exchange rate Adjustments | -15.00K | -105.00K | -- | -- | -3.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.29M | -5.78M | -6.74M | 22.39M | 5.27M |